# Inovio Pharmaceuticals, Inc.: Form 8-K, filed Nov 2, 2023

- Company: [Inovio Pharmaceuticals, Inc.](/companies/ino.md) (CIK 1055726)
- Form: 8-K
- Filed: 2023-11-02
- Accepted by EDGAR: Nov 2, 2023, 16:01 ET
- Period: 2023-11-01
- Accession: 0001193125-23-269347
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1055726/000119312523269347/d580286d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1055726/000119312523269347/

## Items reported

- Item 3.01: Delisting notice

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1055726/000119312523269347/d580286d8k.htm

Filed Nov 2, 2023.
Source: SEC EDGAR, the filing index for accession 0001193125-23-269347. Last ingested by Listed: Nov 11, 2026, 00:27 ET. No prices; not investment advice.